Table 5.
Rieske center reduction* | ||||
---|---|---|---|---|
k1, s−1 | A1 (%) | k2, s−1 | A2 (%) | |
WT | 0.12 | 10 | 1.0 10−3 | 90 |
K117A | 0.24 | 2 | 0.8 10−3 | 98 |
K119A | 0.31 | 13 | 4.2 10−3 | 87 |
H120A | 0.27 | 8 | 1.6 10−3 | 92 |
K121A | n.d. ** | n.d. | 3.6 10−3 | 100 |
Y123A | 0.48 | 9 | 2.2 10−3 | 91 |
5 point mutation | 0.32 | 6 | 1.6 10−3 | 94 |
W94Y | 3.1 | 2 | 0.012 | 98 |
W94F | n.d. | n.d. | 0.040 | 100 |
W94A | 5.9 | 100 | n.d. | n.d. |
An anaerobic solution of PDO (30–40 μM) in 0.1M HEPES, pH 7.8 in the presence of 3 mM phthalate was mixed with anaerobically prepared 2 mM sodium dithionite in the same buffer. Concentrations are presented before mixing.
n.d. – phase not detected